Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Diabetologist
M.B.B.S., M.C.P.S, Ph.D
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Consultant Physician
M.B.B.S., F.C.P.S., Diploma in Diabetes
Endocrinologist
MSc in Diabetes and Endocrine
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Internal Medicine Specialist
M.B.B.S, M.C.P.S, F.C.P.S.
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures